PharmaLundensis AB (XSAT:PHAL) Cyclically Adjusted Book per Share: kr0.26 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:PHAL PharmaLundensis AB XSAT:PHAL
25 GF Score
Price kr0.32
! 1 Warning Sign
View Full Analysis

What is PharmaLundensis AB Cyclically Adjusted Book per Share?

PharmaLundensis AB XSAT:PHAL 25 Cyclically Adjusted Book per Share is kr0.26 as of Mar. 2026. GuruFocus rates XSAT:PHAL with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PharmaLundensis AB's adjusted book value per share for the three months ended in Mar. 2026 was kr0.050. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.26 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PharmaLundensis AB's average Cyclically Adjusted Book Growth Rate was -21.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -14.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of PharmaLundensis AB was 2.30% per year. The lowest was -14.60% per year. And the median was -3.35% per year.

As of today (2026-07-15), PharmaLundensis AB's current stock price is kr0.317. PharmaLundensis AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr0.26. PharmaLundensis AB's Cyclically Adjusted PB Ratio of today is 1.22.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PharmaLundensis AB was 1.21. The lowest was 0.00. And the median was 0.00.


PharmaLundensis AB  (XSAT:PHAL) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PharmaLundensis AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.317/0.26
=1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PharmaLundensis AB was 1.21. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PharmaLundensis AB Cyclically Adjusted Book per Share Related Terms


PharmaLundensis AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PharmaLundensis AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaLundensis AB Cyclically Adjusted Book per Share Chart

PharmaLundensis AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.45 0.40 0.35 0.28

PharmaLundensis AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.32 0.31 0.28 0.26

XSAT:PHAL vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, PharmaLundensis AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaLundensis AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaLundensis AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PharmaLundensis AB's Cyclically Adjusted PB Ratio falls into.


XSAT:PHAL
25GF Score
PharmaLundensis AB XSAT:PHAL
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaLundensis AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaLundensis AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.05/133.5600*133.5600
=0.050

Current CPI (Mar. 2026) = 133.5600.

PharmaLundensis AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.589 101.019 0.779
201609 0.540 101.138 0.713
201612 0.462 102.022 0.605
201703 0.766 102.022 1.003
201706 0.696 102.752 0.905
201709 0.636 103.279 0.822
201712 0.324 103.793 0.417
201803 0.276 103.962 0.355
201806 0.310 104.875 0.395
201809 0.263 105.679 0.332
201812 0.300 105.912 0.378
201903 0.252 105.886 0.318
201906 0.264 106.742 0.330
201909 0.222 107.214 0.277
201912 0.218 107.766 0.270
202003 0.190 106.563 0.238
202006 0.154 107.498 0.191
202009 0.133 107.635 0.165
202012 0.105 108.296 0.129
202103 0.162 108.360 0.200
202106 0.139 108.928 0.170
202109 0.118 110.338 0.143
202112 0.101 112.486 0.120
202203 0.062 114.825 0.072
202206 0.092 118.384 0.104
202209 0.074 122.296 0.081
202212 0.052 126.365 0.055
202303 0.097 127.042 0.102
202306 0.073 129.407 0.075
202309 0.046 130.224 0.047
202312 0.083 131.912 0.084
202403 0.050 132.205 0.051
202406 0.041 132.716 0.041
202409 0.089 132.304 0.090
202412 0.077 132.987 0.077
202503 0.098 132.825 0.099
202506 0.066 133.699 0.066
202509 0.079 133.480 0.079
202512 0.048 133.390 0.048
202603 0.050 133.560 0.050

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr0.26 mean?
PharmaLundensis AB (XSAT:PHAL) has a Cyclically Adjusted Book per Share of kr0.26 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PharmaLundensis AB and its competitors.
Is PharmaLundensis AB's Cyclically Adjusted Book per Share too high?
PharmaLundensis AB's current Cyclically Adjusted Book per Share is kr0.26. Overall, PharmaLundensis AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does PharmaLundensis AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
PharmaLundensis AB's Cyclically Adjusted Book per Share of kr0.26 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PharmaLundensis AB and its competitors. PharmaLundensis AB's current Cyclically Adjusted Book per Share is kr0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaLundensis AB stock overvalued right now?
PharmaLundensis AB (XSAT:PHAL) has a current Cyclically Adjusted Book per Share of kr0.26. The current Cyclically Adjusted Book per Share is kr0.26. PharmaLundensis AB's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PharmaLundensis AB (XSAT:PHAL), the current Cyclically Adjusted Book per Share is kr0.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaLundensis AB Business Description

Address PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.
25GF Score

Get the complete analysis for XSAT:PHAL

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.32
Price